Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data (2014)
- Authors:
- Autor USP: SQUIRE, JEREMY ANDREW - FMRP
- Unidade: FMRP
- Assunto: NEOPLASIAS PROSTÁTICAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Abstracts
- Conference titles: European Human Genetics Conference
-
ABNT
SQUIRE, Jeremy Andrew e GREER, P. e WILLIAMS, J. Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data. 2014, Anais.. Milan: ESHG, 2014. . Acesso em: 12 fev. 2026. -
APA
Squire, J. A., Greer, P., & Williams, J. (2014). Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data. In Abstracts. Milan: ESHG. -
NLM
Squire JA, Greer P, Williams J. Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data. Abstracts. 2014 ;[citado 2026 fev. 12 ] -
Vancouver
Squire JA, Greer P, Williams J. Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data. Abstracts. 2014 ;[citado 2026 fev. 12 ] - A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer
- Extracellular vesicles: evolving factors in stem cell biology
- Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
- In silico shows that PTEN loss and AR overexpression are associated with increased CD8+ T-cell and Treg density and earlier disease recurrence in prostate cancer
- In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in sity hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading
- STAT1-associated intratumoural TH1 immunity predicts chemotherapy resistance in high-grade serous ovarian cancer
- PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy
- Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma
- Application of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for detecting PTEN loss in diagnostic prostate cancer needle biopsies
- Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
